The North America Enteric Disease Testing Market would witness market growth of 2.6% CAGR during the forecast period (2023-2029).
Enteric diseases are tested commonly by two methods, molecular diagnostics and immunodiagnostics. The identification of strains and the isolation of intestinal pathogens are two microbiological applications of molecular diagnostics. Utilizing various molecular diagnostics approaches, disease-causing microbes are also researched. The advent of technologically advanced equipment with higher degrees of accuracy will likely lead to an increase in the use of molecular diagnostics in microbiology.
In addition, molecular diagnostics are used in clinical laboratories as a component of laboratory automation. As a result, the market for enteric disease testing is anticipated to grow throughout the projected period due to the increasing acceptance of molecular diagnostics testing methods.
Even in industrialized nations, enteric diseases with low infectious doses that allow effective person-to-person transmissions, like Shigella and noroviruses, provide a significant concern, particularly in crowded settings. For instance, communities with high levels of household congestion, like the ultraorthodox Jewish population, and children in childcare centers represent major high-risk groups for shigellosis.
The regional demand is driven by the presence of a refined reimbursement structure designed to reduce expenditure levels. In addition, the healthcare industry in this region has a strong infrastructure, with a high purchasing power and an increasing adoption pace of enteric disease testing. In the US, the Cholera and Other Vibrio Illness Surveillance (COVIS) system is a nationwide surveillance system that monitors human infection caused by pathogenic species of the Vibrionaceae family, known to cause cholera and vibriosis. According to the Centers for Disease Control and Prevention (CDC), COVIS reported a total of 1,252 cases of Vibrio infections in 2014. of these, 27% of the patients were hospitalized, and 4% passed away. Therefore, these elements are expected to contribute to the growth of the market.
The US market dominated the North America Enteric Disease Testing Market by Country 2022 and would continue to be a dominant market till 2029; thereby, achieving a market value of $1,280.1 million by 2029. The Canada market is anticipated to grow at a CAGR of 4.9% during (2023 - 2029). Additionally, The Mexico market would witness a CAGR of 4% during (2023 - 2029).
Based on End User, the market is segmented into Hospital Laboratories, Pharmaceutical & Biotechnology Companies, and Academic & Research Institutes. Based on Disease Type, the market is segmented into Bacterial, Viral and Parasitic. Based on Product Type, the market is segmented into Reagents & Consumables and Equipment. Based on Technique, the market is segmented into Immunodiagnostics and Molecular Diagnostics. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Worldwide Enteric Disease Testing Market is Projected to reach USD 4.6 Billion by 2029, at a CAGR of 3.2%
The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Merck KGaA, Thermo Fisher Scientific, Inc., SGS S.A., Eurofins Scientific SE, Bureau Veritas S.A., Intertek Group PLC, TÜV Nord Group, PerkinElmer, Inc., Becton, Dickinson and Company and Neogen Corporation.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospital Laboratories
- Pharmaceutical & Biotechnology Companies
- Academic & Research Institutes
By Disease Type
- Bacterial
- Viral
- Parasitic
By Product Type
- Reagents & Consumables
- Equipment
By Technique
- Immunodiagnostics
- Molecular Diagnostics
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Merck KGaA
- Thermo Fisher Scientific, Inc.
- SGS S.A.
- Eurofins Scientific SE
- Bureau Veritas S.A.
- Intertek Group PLC
- TÜV Nord Group
- PerkinElmer, Inc.
- Becton, Dickinson and Company
- Neogen Corporation
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Enteric Disease Testing Market, by End User
1.4.2 North America Enteric Disease Testing Market, by Disease Type
1.4.3 North America Enteric Disease Testing Market, by Product Type
1.4.4 North America Enteric Disease Testing Market, by Technique
1.4.5 North America Enteric Disease Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
Chapter 4. North America Enteric Disease Testing Market by End User
4.1 North America Hospital Laboratories Market by Country
4.2 North America Pharmaceutical & Biotechnology Companies Market by Country
4.3 North America Academic & Research Institutes Market by Country
Chapter 5. North America Enteric Disease Testing Market by Disease Type
5.1 North America Bacterial Market by Country
5.2 North America Viral Market by Country
5.3 North America Parasitic Market by Country
Chapter 6. North America Enteric Disease Testing Market by Product Type
6.1 North America Reagents & Consumables Market by Country
6.2 North America Equipment Market by Country
Chapter 7. North America Enteric Disease Testing Market by Technique
7.1 North America Immunodiagnostics Market by Country
7.2 North America Molecular Diagnostics Market by Country
Chapter 8. North America Enteric Disease Testing Market by Country
8.1 US Enteric Disease Testing Market
8.1.1 US Enteric Disease Testing Market by End User
8.1.2 US Enteric Disease Testing Market by Disease Type
8.1.3 US Enteric Disease Testing Market by Product Type
8.1.4 US Enteric Disease Testing Market by Technique
8.2 Canada Enteric Disease Testing Market
8.2.1 Canada Enteric Disease Testing Market by End User
8.2.2 Canada Enteric Disease Testing Market by Disease Type
8.2.3 Canada Enteric Disease Testing Market by Product Type
8.2.4 Canada Enteric Disease Testing Market by Technique
8.3 Mexico Enteric Disease Testing Market
8.3.1 Mexico Enteric Disease Testing Market by End User
8.3.2 Mexico Enteric Disease Testing Market by Disease Type
8.3.3 Mexico Enteric Disease Testing Market by Product Type
8.3.4 Mexico Enteric Disease Testing Market by Technique
8.4 Rest of North America Enteric Disease Testing Market
8.4.1 Rest of North America Enteric Disease Testing Market by End User
8.4.2 Rest of North America Enteric Disease Testing Market by Disease Type
8.4.3 Rest of North America Enteric Disease Testing Market by Product Type
8.4.4 Rest of North America Enteric Disease Testing Market by Technique
Chapter 9. Company Profiles
9.1 Thermo Fisher Scientific, Inc.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Partnerships, Collaborations, and Agreements:
9.1.5.2 Product Launches and Product Expansions:
9.1.5.3 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 Becton, Dickinson and Company
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental and Regional Analysis
9.2.4 Research & Development Expense
9.2.5 SWOT Analysis
9.3 Neogen Corporation
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expenses
9.3.5 Recent strategies and developments:
9.3.5.1 Acquisition and Mergers:
9.4 Bureau Veritas S.A.
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Acquisition and Mergers:
9.5 SGS S.A.
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental Analysis
9.5.4 Recent strategies and developments:
9.5.4.1 Partnerships, Collaborations, and Agreements:
9.6 Eurofins Scientific SE
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Regional Analysis
9.6.4 Recent strategies and developments:
9.6.4.1 Acquisition and Mergers:
9.7 Merck KGaA
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expense
9.8 PerkinElmer, Inc.
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.9 Intertek Group PLC
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 Research & Development Expenses
9.10. TÜV Nord Group
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
TABLE 1 North America Enteric Disease Testing Market, 2019 - 2022, USD Million
TABLE 2 North America Enteric Disease Testing Market, 2023 - 2029, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Enteric Disease Testing Market
TABLE 4 Product Launches And Product Expansions– Enteric Disease Testing Market
TABLE 5 Acquisition and Mergers– Enteric Disease Testing Market
TABLE 6 North America Enteric Disease Testing Market by End User, 2019 - 2022, USD Million
TABLE 7 North America Enteric Disease Testing Market by End User, 2023 - 2029, USD Million
TABLE 8 North America Hospital Laboratories Market by Country, 2019 - 2022, USD Million
TABLE 9 North America Hospital Laboratories Market by Country, 2023 - 2029, USD Million
TABLE 10 North America Pharmaceutical & Biotechnology Companies Market by Country, 2019 - 2022, USD Million
TABLE 11 North America Pharmaceutical & Biotechnology Companies Market by Country, 2023 - 2029, USD Million
TABLE 12 North America Academic & Research Institutes Market by Country, 2019 - 2022, USD Million
TABLE 13 North America Academic & Research Institutes Market by Country, 2023 - 2029, USD Million
TABLE 14 North America Enteric Disease Testing Market by Disease Type, 2019 - 2022, USD Million
TABLE 15 North America Enteric Disease Testing Market by Disease Type, 2023 - 2029, USD Million
TABLE 16 North America Bacterial Market by Country, 2019 - 2022, USD Million
TABLE 17 North America Bacterial Market by Country, 2023 - 2029, USD Million
TABLE 18 North America Viral Market by Country, 2019 - 2022, USD Million
TABLE 19 North America Viral Market by Country, 2023 - 2029, USD Million
TABLE 20 North America Parasitic Market by Country, 2019 - 2022, USD Million
TABLE 21 North America Parasitic Market by Country, 2023 - 2029, USD Million
TABLE 22 North America Enteric Disease Testing Market by Product Type, 2019 - 2022, USD Million
TABLE 23 North America Enteric Disease Testing Market by Product Type, 2023 - 2029, USD Million
TABLE 24 North America Reagents & Consumables Market by Country, 2019 - 2022, USD Million
TABLE 25 North America Reagents & Consumables Market by Country, 2023 - 2029, USD Million
TABLE 26 North America Equipment Market by Country, 2019 - 2022, USD Million
TABLE 27 North America Equipment Market by Country, 2023 - 2029, USD Million
TABLE 28 North America Enteric Disease Testing Market by Technique, 2019 - 2022, USD Million
TABLE 29 North America Enteric Disease Testing Market by Technique, 2023 - 2029, USD Million
TABLE 30 North America Immunodiagnostics Market by Country, 2019 - 2022, USD Million
TABLE 31 North America Immunodiagnostics Market by Country, 2023 - 2029, USD Million
TABLE 32 North America Molecular Diagnostics Market by Country, 2019 - 2022, USD Million
TABLE 33 North America Molecular Diagnostics Market by Country, 2023 - 2029, USD Million
TABLE 34 North America Enteric Disease Testing Market by Country, 2019 - 2022, USD Million
TABLE 35 North America Enteric Disease Testing Market by Country, 2023 - 2029, USD Million
TABLE 36 US Enteric Disease Testing Market, 2019 - 2022, USD Million
TABLE 37 US Enteric Disease Testing Market, 2023 - 2029, USD Million
TABLE 38 US Enteric Disease Testing Market by End User, 2019 - 2022, USD Million
TABLE 39 US Enteric Disease Testing Market by End User, 2023 - 2029, USD Million
TABLE 40 US Enteric Disease Testing Market by Disease Type, 2019 - 2022, USD Million
TABLE 41 US Enteric Disease Testing Market by Disease Type, 2023 - 2029, USD Million
TABLE 42 US Enteric Disease Testing Market by Product Type, 2019 - 2022, USD Million
TABLE 43 US Enteric Disease Testing Market by Product Type, 2023 - 2029, USD Million
TABLE 44 US Enteric Disease Testing Market by Technique, 2019 - 2022, USD Million
TABLE 45 US Enteric Disease Testing Market by Technique, 2023 - 2029, USD Million
TABLE 46 Canada Enteric Disease Testing Market, 2019 - 2022, USD Million
TABLE 47 Canada Enteric Disease Testing Market, 2023 - 2029, USD Million
TABLE 48 Canada Enteric Disease Testing Market by End User, 2019 - 2022, USD Million
TABLE 49 Canada Enteric Disease Testing Market by End User, 2023 - 2029, USD Million
TABLE 50 Canada Enteric Disease Testing Market by Disease Type, 2019 - 2022, USD Million
TABLE 51 Canada Enteric Disease Testing Market by Disease Type, 2023 - 2029, USD Million
TABLE 52 Canada Enteric Disease Testing Market by Product Type, 2019 - 2022, USD Million
TABLE 53 Canada Enteric Disease Testing Market by Product Type, 2023 - 2029, USD Million
TABLE 54 Canada Enteric Disease Testing Market by Technique, 2019 - 2022, USD Million
TABLE 55 Canada Enteric Disease Testing Market by Technique, 2023 - 2029, USD Million
TABLE 56 Mexico Enteric Disease Testing Market, 2019 - 2022, USD Million
TABLE 57 Mexico Enteric Disease Testing Market, 2023 - 2029, USD Million
TABLE 58 Mexico Enteric Disease Testing Market by End User, 2019 - 2022, USD Million
TABLE 59 Mexico Enteric Disease Testing Market by End User, 2023 - 2029, USD Million
TABLE 60 Mexico Enteric Disease Testing Market by Disease Type, 2019 - 2022, USD Million
TABLE 61 Mexico Enteric Disease Testing Market by Disease Type, 2023 - 2029, USD Million
TABLE 62 Mexico Enteric Disease Testing Market by Product Type, 2019 - 2022, USD Million
TABLE 63 Mexico Enteric Disease Testing Market by Product Type, 2023 - 2029, USD Million
TABLE 64 Mexico Enteric Disease Testing Market by Technique, 2019 - 2022, USD Million
TABLE 65 Mexico Enteric Disease Testing Market by Technique, 2023 - 2029, USD Million
TABLE 66 Rest of North America Enteric Disease Testing Market, 2019 - 2022, USD Million
TABLE 67 Rest of North America Enteric Disease Testing Market, 2023 - 2029, USD Million
TABLE 68 Rest of North America Enteric Disease Testing Market by End User, 2019 - 2022, USD Million
TABLE 69 Rest of North America Enteric Disease Testing Market by End User, 2023 - 2029, USD Million
TABLE 70 Rest of North America Enteric Disease Testing Market by Disease Type, 2019 - 2022, USD Million
TABLE 71 Rest of North America Enteric Disease Testing Market by Disease Type, 2023 - 2029, USD Million
TABLE 72 Rest of North America Enteric Disease Testing Market by Product Type, 2019 - 2022, USD Million
TABLE 73 Rest of North America Enteric Disease Testing Market by Product Type, 2023 - 2029, USD Million
TABLE 74 Rest of North America Enteric Disease Testing Market by Technique, 2019 - 2022, USD Million
TABLE 75 Rest of North America Enteric Disease Testing Market by Technique, 2023 - 2029, USD Million
TABLE 76 Key Information – Thermo Fisher Scientific, Inc.
TABLE 77 Key information – Becton, Dickinson and Company
TABLE 78 Key Information – Neogen Corporation
TABLE 79 Key Information – Bureau Veritas S.A.
TABLE 80 Key Information – SGS S.A.
TABLE 81 Key Information – Eurofins Scientific SE
TABLE 82 key Information – Merck KGaA
TABLE 83 key Information – PerkinElmer, Inc.
TABLE 84 Key Information – Intertek Group PLC
TABLE 85 Key Information – TÜV NORD GROUP
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 4 Recent strategies and developments: Thermo Fisher Scientific, Inc.
FIG 5 Swot analysis: thermo fisher scientific, inc.
FIG 6 Swot analysis: Becton, Dickinson and company